Nidhi Prabhakar

Dr. Nidhi Prabhakar


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2021 in Radiology
Verified
Journal Article
Closed access
Mandeep GargMandeep Garg
Mandeep Garg
NPNidhi Prabhakar
Nidhi Prabhakar
VMValliappan Muthu
Valliappan Muthu
SFShameema Farookh
Shameema Farookh
HKHarsimran Kaur
Harsimran Kaur
RARitesh Agarwal
Ritesh Agarwal
COVID-19–associated pulmonary mucormycosis (CAPM) has higher mortality compared with nonpulmonary COVID-19 mucormycosis. The most common CT findings seen in CAPM are consolidation and cavitation.

11 January 2023 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
PDF file
Mandeep GargMandeep Garg
Mandeep Garg
HBHarsimran Bhatia
Harsimran Bhatia
TCTany Chandra
Tany Chandra
UDUma Debi
Uma Debi
ISInderpaul Sehgal
Inderpaul Sehgal
RARitesh Agarwal
Ritesh Agarwal
: Chronic pulmonary aspergillosis (CPA) is a life-threatening respiratory fungal infection that is almost exclusively seen in patients with preexisting structural lung disease with no or mild immunosuppression. The clinical presentation and imaging findings are varied and often pose a diagnostic challenge; and the disease is often present for a long time before being correctly diagnosed. High-resolution chest computed tomography is the imaging modality of choice because it helps identify various forms of CPA, which can range from a simple aspergilloma and chronic cavitary form, to the subacute invasive and end-stage fibrotic form. The knowledge of the imaging features of this disease cannot be overemphasized because it can assist the clinician in reaching at an early diagnosis and timely initiation of appropriate antifungal therapy, thereby improving patient management and treatment outcome. Moreover, imaging also plays a pivotal role during follow-up in patients of CPA to assess the treatment response. In the current review, we present an illustrative review of radiologic patterns seen in various forms of CPA.

18 January 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
Mandeep GargMandeep Garg
Mandeep Garg
SDShritik Devkota
Shritik Devkota
NPNidhi Prabhakar
Nidhi Prabhakar
UDUma Debi
Uma Debi
MKManinder Kaur
Maninder Kaur
MSManavjit Singh Sandhu
Manavjit Singh Sandhu
The rapid increase in the number of CT acquisitions during the COVID-19 pandemic raised concerns about increased radiation exposure to patients and the resultant radiation-induced health risks. It prompted researchers to explore newer CT techniques like ultra-low dose CT (ULDCT), which could improve patient safety. Our aim was to study the utility of ultra-low dose CT (ULDCT) chest in the evaluation of acute COVID-19 pneumonia with standard-dose CT (SDCT) chest as a reference standard. This was a prospective study approved by the institutional review board. 60 RT-PCR positive COVID-19 patients with valid indication for CT chest underwent SDCT and ULDCT. ULDCT and SDCT were compared in terms of objective (noise and signal-to-noise ratio) and subjective (noise, sharpness, artifacts and diagnostic confidence) image quality, various imaging patterns of COVID-19, CT severity score and effective radiation dose. The sensitivity, specificity, positive and negative predictive value, and diagnostic accuracy of ULDCT for detecting lung lesions were calculated by taking SDCT as a reference standard. The mean age of subjects was 47.2 ± 10.7 years, with 66.67% being men. 90% of ULDCT scans showed no/minimal noise and sharp images, while 93.33% had image quality of high diagnostic confidence. The major imaging findings detected by SDCT were GGOs (90%), consolidation (76.67%), septal thickening (60%), linear opacities (33.33%), crazy-paving pattern (33.33%), nodules (30%), pleural thickening (30%), lymphadenopathy (30%) and pleural effusion (23.33%). Sensitivity, specificity and diagnostic accuracy of ULDCT for detecting most of the imaging patterns were 100% (p < 0.001); except for GGOs (sensitivity: 92.59%, specificity: 100%, diagnostic accuracy: 93.33%), consolidation (sensitivity: 100%, specificity: 71.43%, diagnostic accuracy: 93.33%) and linear opacity (sensitivity: 90.00%, specificity: 100%, diagnostic accuracy: 96.67%). CT severity score (range: 15–25) showed 100% concordance on SDCT and ULDCT, while effective radiation dose was 4.93 ± 1.11 mSv and 0.26 ± 0.024 mSv, respectively. A dose reduction of 94.38 ± 1.7% was achieved with ULDCT. Compared to SDCT, ULDCT chest yielded images of reasonable and comparable diagnostic quality with the advantage of significantly reduced radiation dose; thus, it can be a good alternative to SDCT in the evaluation of COVID-19 pneumonia.

1 February 2023 in RadioGraphics
Verified
Journal Article
Closed access
ASAkshay Kumar Saxena
Akshay Kumar Saxena
NNNiveditha Naik
Niveditha Naik
ABAnmol Bhatia
Anmol Bhatia
NPNidhi Prabhakar
Nidhi Prabhakar
KSKushaljit Singh Sodhi
Kushaljit Singh Sodhi

3 January 2021 in BJR|Open
Verified
Journal Article
Open access
Mandeep GargMandeep Garg
Mandeep Garg
NPNidhi Prabhakar
Nidhi Prabhakar
HBHarsimran Bhatia
Harsimran Bhatia
SDSahajal Dhooria
Sahajal Dhooria
UDUma Debi
Uma Debi
MSM S Sandhu
M S Sandhu
A significant number of patients after initial recovery from COVID-19 continue to experience lingering symptoms of the disease that may last for weeks or even months. Lungs being the most commonly affected organ by COVID-19, bear the major brunt of the disease and thus it is imperative to be aware of the evolution of the pulmonary parenchymal changes over time. CT chest is the imaging modality of choice to evaluate post-COVID lungs. Persistent ground-glass opacities, septal thickening, parenchymal bands, crazy-paving, traction bronchiectasis and consolidation constitute the commonly encountered imaging patterns seen on CT in post-COVID-19 lungs. Few vulnerable patients can develop lung fibrosis and show honeycombing on CT. Additionally, many complications like superadded infections (bacterial and fungal), pulmonary thromboembolism and pseudoaneurysm formation are also being reported. In the present pictorial review, we have tried to show the entire CT spectrum of sequelae of COVID-19 pneumonia and commonly associated infections and vascular complications.

23 November 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
RSRohit Srinivas
Rohit Srinivas
Mandeep GargMandeep Garg
Mandeep Garg
UDUma Debi
Uma Debi
NPNidhi Prabhakar
Nidhi Prabhakar
SDSahajal Dhooria
Sahajal Dhooria
MSManavjit Singh Sandhu
Manavjit Singh Sandhu
Chronic obstructive pulmonary disease (COPD) is a chronic respiratory condition characterized by obstruction of airways and emphysematous lung tissue damage, with associated hypoxic vasoconstriction in the affected lung parenchyma. In our study, we evaluate the role of oxygen-enhanced (OE) MRI and dynamic contrast enhanced (DCE)-MRI in COPD patients for assessment of ventilation and perfusion defects and compared their severity with clinical severity. A total of 60 patients with COPD (diagnosed based on clinical and spirometry findings) and 2 controls with normal spirometry and no history of COPD were enrolled. All patients underwent MRI within 1 month of spirometry. OE-MRI was performed by administering oxygen at 12 L/min for 4 min to look for ventilation defects. DCE-MRI was performed by injecting intravenous gadolinium contrast, and perfusion abnormalities were detected by subtracting the non-enhanced areas from the first pass perfusion contrast images. A total of 87% of the subjects demonstrated ventilation and perfusion abnormalities on MRI independently. The lobe-wise distribution of ventilation and perfusion abnormalities correlated well with each other and was statistically significant in all lobes (p < 0.05). The severity of ventilation-perfusion defects also correlated well with clinical severity, as their median value (calculated using a Likert rating scale) was significantly lower in patients in the Global initiative for chronic Obstructive Lung Disease (GOLD) I/II group (3.25) compared to the GOLD III/IV group (7.25). OE- and DCE-MRI provide functional information about ventilation-perfusion defects and their regional distribution, which correlates well with clinical severity in patients with COPD.